Healthcare private equity firm Health Evolution Partners announced today that Braden Kelly will serve as its new Investment Partner. Kelley's former position in the company was senior advisor to the Health Evolution Partners Growth Buyout Fund.

He was a member of the board of directors of Censeo Health last year. Censeo is a portfolio company of  Health Evolution Partners.

"We value his private equity and investment experience and look forward to his leadership on investment opportunities and with our portfolio companies," said David J. Ballier, MD, PhD, managing partner and chief executive of Health Evolution Partners.

Kelley also worked as the managing director of General Atlantic LLC, an US$18 billion investment firm for over 12 years.

"Through my relationship with Health Evolution Partners, I have been privileged to work with a great group of talented people and an innovative and strong collection of companies delivering value across the health care landscape," commented Kelly on his new position.

"I am excited to begin a new chapter with the team," he followed.

Kelley has a degree in finance and business economics from the University of Notre Dame, where he finished summa cum laude.